Multilocus genetic profiling to empower drug trials and predict brain atrophy

NeuroImage: Clinical

Volumn 2, Issue 1, 2013, Pages 827-835

  Kohannim, Omid ^a   Hua, Xue ^a   Rajagopalan, Priya ^a   Hibar, Derrek P ^a   Jahanshad, Neda ^a   Grill, Joshua D ^a   Apostolova, Liana G ^a   Toga, Arthur W ^a   Jack, Clifford R ^b   Weiner, Michael W ^c,d   Thompson, Paul M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Brain atrophy; Clinical trial enrichment; Genetic risk score; Genetics; Neuroimaging

Indexed keywords

APOLIPOPROTEIN E;

ADOLESCENT; ALZHEIMER DISEASE; AMNESIA; ARTICLE; BRAIN ATROPHY; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DRUG SCREENING; ENTORHINAL CORTEX; FEMALE; FOLLOW UP; FUNCTIONAL NEUROIMAGING; GENE EXPRESSION PROFILING; GENETIC RISK; GENOTYPE; HIPPOCAMPUS; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; MULTILOCUS GENETIC PROFILING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; TEMPORAL LOBE;

EID: 84880276343     PISSN: None     EISSN: 22131582     Source Type: Journal    
DOI: 10.1016/j.nicl.2013.05.007     Document Type: Article

References (62)

1. L.A. Beckett, D.J. Harvey, A. Gamst, M. Donohue, J. Kornak, H. Zhang, J.H. Kuo, and Alzheimer's Disease Neuroimaging Initiative The Alzheimer's Disease Neuroimaging Initiative: annual change in biomarkers and clinical outcomes Alzheimer's & Dementia 6 3 2010 257 264
2. L. Bertram, M.B. McQueen, K. Mullin, D. Blacker, and R.E. Tanzi Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database Nature Genetics 39 1 2007 17 23 (Pubitemid 46026496)
3. A. Biffi, C.D. Anderson, R.S. Desikan, M. Sabuncu, L. Cortellini, N. Schmansky, D. Salat, J. Rosand, and Alzheimer's Disease Neuroimaging Initiative Genetic variation and neuroimaging measures in Alzheimer disease Archives of Neurology 67 6 2010 677 685
4. J. Bralten, B. Franke, A. Arias-Vásquez, A. Heister, H.G. Brunner, G. Fernández, and M. Rijpkema CR1 genotype is associated with entorhinal cortex volume in young healthy adults Neurobiology of Aging 32 11 2011 2106.e7 2106.e11
5. M.N. Braskie, J.M. Ringman, and P.M. Thompson Neuroimaging measures as endophenotypes in Alzheimer's disease International Journal of Alzheimer's Disease 490140 2011
6. M.N. Braskie, N. Jahanshad, J.L. Stein, M. Barysheva, K.L. McMahon, G.I. de Zubicaray, N.G. Martin, M.J. Wright, J.M. Ringman, A.W. Toga, and P.M. Thompson Common Alzheimer's disease risk variant within the CLU gene affects white matter microstructure in young adults Journal of Neuroscience 31 18 2011 6764 6770
7. A.C. Burggren, M.M. Zeineh, A.D. Ekstrom, M.N. Braskie, P.M. Thompson, G.W. Small, and S.Y. Bookheimer Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers NeuroImage 41 4 2008 1177 1183
8. M.M. Carrasquillo, O. Belbin, T.A. Hunter, L. Ma, G.D. Bisceglio, F. Zou, J.E. Crook, V.S. Pankratz, D.W. Dickson, N.R. Graff-Radford, R.C. Petersen, K. Morgan, and S.G. Younkin Replication of CLU, CR1, and PICALM associations with Alzheimer disease Archives of Neurology 67 8 2010 961 964
9. J.R. Cockrell, and M.F. Folstein Mini-Mental State Examination (MMSE) Psychopharmacology Bulletin 24 4 1988 689 692
10. J.J. Corneveaux, A.J. Myers, A.N. Allen, J.J. Pruzin, M. Ramirez, A. Engel, M.A. Nalls, K. Chen, W. Lee, K. Chewning, S.E. Villa, H.B. Meechoovet, J.D. Gerber, D. Frost, H.L. Benson, S. O'Reilly, L.B. Chibnik, J.M. Shulman, A.B. Singleton, D.W. Craig, K.R. Van Keuren-Jensen, T. Dunckley, D.A. Bennett, P.L. De Jager, C. Heward, J. Hardy, E.M. Reiman, and M.J. Huentelman Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals Human Molecular Genetics 19 16 2010 3295 3301
11. P.E. Cramer, J.R. Cirrito, D.W. Wesson, C.Y. Lee, J.C. Karlo, A.E. Zinn, B.T. Casali, J.L. Restivo, W.D. Goebel, M.J. James, K.R. Brunden, D.A. Wilson, and G.E. Landreth ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models Science 335 6075 2012 1503 1506
12. F. Crivello, H. Lemaître, C. Dufouil, B. Grassiot, N. Delcroix, N. Tzourio-Mazoyer, C. Tzourio, and B. Mazoyer Effects of ApoE-epsilon4 allele load and age on the rates of grey matter and hippocampal volumes loss in a longitudinal cohort of 1186 healthy elderly persons Neuroimage 53 3 2010 1064 1069
13. C. Cruchaga, P. Nowotny, J.S. Kauwe, P.G. Ridge, S. Bertelsen, A. Hinrichs, A.M. Fagan, D.M. Holtzman, J.C. Morris, A.M. Goate, and Alzheimer's Disease Neuroimaging Initiative Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease Archives of Neurology 68 8 2011 1013 1019
14. P.L. De Jager, L.B. Chibnik, J. Cui, J. Reischl, S. Lehr, K.C. Simon, C. Aubin, D. Bauer, J.F. Heubach, R. Sandbrink, M. Tyblova, P. Lelkova, Steering committee of the BENEFIT study, Steering committee of the BEYOND study, Steering committee of the LTF study, Steering committee of the CCR1 study, E. Havrdova, C. Pohl, D. Horakova, A. Ascherio, D.A. Hafler, and E.W. Karlson Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score Lancet Neurology 8 12 2009 1111 1119
15. L.A. Farrer, L.A. Cupples, J.L. Haines, B. Hyman, W.A. Kukull, R. Mayeux, R.H. Myers, M.A. Pericak-Vance, N. Risch, and C.M. van Duijn Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium JAMA 278 16 1997 1349 1356 (Pubitemid 27449696)
16. R. Ferrari, J.H. Moreno, A.T. Minhajuddin, S.E. O'Bryant, J.S. Reisch, R.C. Barber, and P. Momeni Implication of common and disease specific variants in CLU, CR1 and PICALM Neurobiology of Aging 33 8 2012 1846.e7 1846.e18
17. G.B. Frisoni, N.C. Fox, C.R. Jack Jr., P. Scheltens, and P.M. Thompson The clinical use of structural MRI in Alzheimer's disease Nature Reviews Neurology 6 2 2010 67 77
18. J. Gunter, M. Bernstein, B. Borowski, J. Felmlee, D. Blezek, and R. Mallozzi Validation testing of the MRI calibration phantom for the Alzheimer's Disease Neuroimaging Initiative study Proceedings on International Society for Magnetic Resonance in Medicine 14 2006
19. D. Harold, R. Abraham, P. Hollingworth, R. Sims, A. Gerrish, M.L. Hamshere, J.S. Pahwa, V. Moskvina, K. Dowzell, A. Williams, N. Jones, C. Thomas, A. Stretton, A.R. Morgan, S. Lovestone, J. Powell, P. Proitsi, M.K. Lupton, C. Brayne, D.C. Rubinsztein, M. Gill, B. Lawlor, A. Lynch, K. Morgan, K.S. Brown, P.A. Passmore, D. Craig, B. McGuinness, S. Todd, C. Holmes, D. Mann, A.D. Smith, S. Love, P.G. Kehoe, J. Hardy, S. Mead, N. Fox, M. Rossor, J. Collinge, W. Maier, F. Jessen, B. Schürmann, H. van den Bussche, I. Heuser, J. Kornhuber, J. Wiltfang, M. Dichgans, L. Frölich, H. Hampel, M. Hüll, D. Rujescu, A.M. Goate, J.S. Kauwe, C. Cruchaga, P. Nowotny, J.C. Morris, K. Mayo, K. Sleegers, K. Bettens, S. Engelborghs, P.P. De Deyn, C. Van Broeckhoven, G. Livingston, N.J. Bass, H. Gurling, A. McQuillin, R. Gwilliam, P. Deloukas, A. Al-Chalabi, C.E. Shaw, M. Tsolaki, A.B. Singleton, R. Guerreiro, T.W. Mühleisen, M.M. Nöthen, S. Moebus, K.H. Jöckel, N. Klopp, H.E. Wichmann, M.M. Carrasquillo, V.S. Pankratz, S.G. Younkin, P.A. Holmans, M. O'Donovan, M.J. Owen, and J. Williams Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease Nature Genetics 41 10 2009 1088 1093
20. D.P. Hibar, J.L. Stein, O. Kohannim, N. Jahanshad, A.J. Saykin, L. Shen, S. Kim, N. Pankratz, T. Foroud, M.J. Huentelman, S.G. Potkin, C.R. Jack Jr., M.W. Weiner, A.W. Toga, P.M. Thompson, and Alzheimer's Disease Neuroimaging Initiative Voxelwise gene-wide association study (vGeneWAS). Multivariate gene-based association testing in 731 elderly subjects NeuroImage 56 4 2011 1875 1891
21. D.P. Hibar, J.L. Stein, N. Jahanshad, O. Kohannim, A.W. Toga, K.L. McMahon, G.I. de Zubicaray, G.W. Montgomery, N.G. Martin, M.J. Wright, M.W. Weiner, and P.M. Thompson Exhaustive Search of the SNP-SNP Interactome Identifies Replicated Epistatic Effects on Brain Volume, MICCAI 2013, Nagoya, Japan, Sept. 22-26 2013 (in press)
22. P. Hollingworth, D. Harold, R. Sims, A. Gerrish, J.-C. Lambert, M.M. Carrasquillo, R. Abraham, M.L. Hamshere, J. Singh Pahwa, V. Moskvina, K. Dowzell, N. Jones, A. Stretton, C. Thomas, A. Richards, D. Ivanov, C. Widdowson, J. Chapman, S. Lovestone, J. Powell, P. Proitsi, M.K. Lupton, C. Brayne, D.C. Rubinsztein, M. Gill, B. Lawlor, A. Lynch, K.S. Brown, P.A. Passmore, D. Craig, B. McGuinness, S. Todd, C. Holmes, D. Mann, A.D. Smith, H. Beaumont, D. Warden, G. Wilcock, S. Love, P.G. Kehoe, N.M. Hooper, E.R.L.C. Vardy, J. Hardy, S. Mead, N.C. Fox, M. Rossor, J. Collinge, W. Maier, F. Jessen, B. Schürmann, E. Rüther, R. Heun, H. Kölsch, H. van den Bussche, I. Heuser, J. Kornhuber, J. Wiltfang, M. Dichgans, L. Frölich, H. Hampel, M. Hüll, J. Gallacher, D. Rujescu, I. Giegling, A.M. Goate, J.S.K. Kauwe, C. Cruchaga, P. Nowotny, J.C. Morris, K. Mayo, K. Sleegers, K. Bettens, S. Engelborghs, P.P. De Deyn, C. Van Broeckhoven, G. Livingston, N.J. Bass, H. Gurling, A. McQuillin, R. Gwilliam, P. Deloukas, A. Al-Chalabi, C.E. Shaw, M. Tsolaki, A.B. Singleton, R. Guerreiro, T.W. Mühleisen, M.M. Nöthen, S. Moebus, K.-H. Jöckel, N. Klopp, H.-E. Wichmann, V.S. Pankratz, S.B. Sando, J.O. Aasly, M. Barcikowska, Z.K. Wszolek, D.W. Dickson, N.R. Graff-Radford, R.C. Petersen, the Alzheimer's Disease Neuroimaging Initiative, C.M. van Duijn, M.M.B. Breteler, M.A. Ikram, A.L. DeStefano, A.L. Fitzpatrick, O. Lopez, L.J. Launer, S. Seshadri, CHARGE consortium, C. Berr, D. Campion, J. Epelbaum, J.-F. Dartigues, C. Tzourio, A. Alpérovitch, M. Lathrop, EADI1 consortium, T.M. Feulner, P. Friedrich, C. Riehle, M. Krawczak, S. Schreiber, M. Mayhaus, S. Nicolhaus, S. Wagenpfeil, S. Steinberg, H. Stefansson, K. Stefansson, J. Snædal, S. Björnsson, P.V. Jonsson, V. Chouraki, B. Genier-Boley, M. Hiltunen, H. Soininen, O. Combarros, D. Zelenika, M. Delepine, M.J. Bullido, F. Pasquier, I. Mateo, A. Frank-Garcia, E. Porcellini, O. Hanon, E. Coto, V. Alvarez, P. Bosco, G. Siciliano, M. Mancuso, F. Panza, V. Solfrizzi, B. Nacmias, S. Sorbi, P. Bossù, P. Piccardi, B. Arosio, G. Annoni, D. Seripa, A. Pilotto, E. Scarpini, D. Galimberti, A. Brice, D. Hannequin, F. Licastro, L. Jones, P.A. Holmans, T. Jonsson, M. Riemenschneider, K. Morgan, S.G. Younkin, M.J. Owen, M. O'Donovan, P. Amouyel, and J. Williams Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease Nature Genetics 43 5 2011 429 435
23. P. Holton, M. Ryten, M. Nalls, D. Trabzuni, M.E. Weale, D. Hernandez, H. Crehan, J.R. Gibbs, R. Mayeux, J.L. Haines, L.A. Farrer, M.A. Pericak-Vance, G.D. Schellenberg, Alzheimer's Disease Genetics Consortium, M. Ramirez-Restrepo, A. Engel, A.J. Myers, J.J. Corneveaux, M.J. Huentelman, A. Dillman, M.R. Cookson, E.M. Reiman, A. Singleton, J. Hardy, R. Guerreiro, L.G. Apostolova, S.E. Arnold, C.T. Baldwin, R. Barber, M.M. Barmada, T.G. Beach, G.W. Beecham, D. Beekly, D.A. Bennett, E.H. Bigio, T.D. Bird, D. Blacker, B.F. Boeve, J.D. Bowen, A. Boxer, J.R. Burke, J. Buros, J.D. Buxbaum, N.J. Cairns, L.B. Cantwell, C. Cao, C.S. Carlson, R.M. Carney, M.M. Carrasquillo, S.L. Carroll, H.C. Chui, D.G. Clark, C.W. Cotman, P.K. Crane, E.A. Crocco, C. Cruchaga, J.L. Cummings, P.L. De Jager, C. DeCarli, S.T. DeKosky, F.Y. Demirci, R. Diaz-Arrastia, M. Dick, D.W. Dickson, R. Duara, W.G. Ellis, N. Ertekin-Taner, D. Evans, K.M. Faber, K.B. Fallon, M.R. Farlow, S. Ferris, T.M. Foroud, M.P. Frosch, D.R. Galasko, M. Ganguli, M. Gearing, D.H. Geschwind, B. Ghetti, J.R. Gilbert, S. Gilman, B. Giordani, J.D. Glass, A.M. Goate, N.R. Graff-Radford, R.C. Green, J.H. Growdon, H. Hakonarson, R.L. Hamilton, L.E. Harrell, E. Head, L.S. Honig, C.M. Hulette, B.T. Hyman, G.P. Jarvik, G.A. Jicha, L.W. Jin, G. Jun, M.I. Kamboh, J. Karlawish, A. Karydas, J.S. Kauwe, J.A. Kaye, R. Kim, E.H. Koo, N.W. Kowall, P. Kramer, W.A. Kukull, J.J. Lah, E.B. Larson, A.I. Levey, A.P. Lieberman, O.L. Lopez, K.L. Lunetta, W.J. Mack, D.C. Marson, E.R. Martin, F. Martiniuk, D.C. Mash, E. Masliah, W.C. McCormick, S.M. McCurry, A.N. McDavid, A.C. McKee, M. Mesulam, B.L. Miller, C.A. Miller, J.W. Miller, T.J. Montine, J.C. Morris, A.C. Naj, P. Nowotny, J.E. Parisi, E. Peskind, R.C. Petersen, W.W. Poon, H. Potter, J.F. Quinn, A. Raj, R.A. Rajbhandary, M. Raskind, B. Reisberg, C. Reitz, J.M. Ringman, E.D. Roberson, E. Rogaeva, R.N. Rosenberg, M. Sano, A.J. Saykin, J.A. Schneider, L.S. Schneider, W.W. Seeley, M.L. Shelanski, C.D. Smith, J.A. Sonnen, S. Spina, P. St George-Hyslop, R.A. Stern, R.E. Tanzi, J.Q. Trojanowski, J.C. Troncoso, D.W. Tsuang, O. Valladares, V.M. Van Deerlin, B.N. Vardarajan, H.V. Vinters, J.P. Vonsattel, L.S. Wang, S. Weintraub, K.A. Welsh-Bohmer, J. Williamson, R.L. Woltjer, C.B. Wright, and S.G. Younkin Initial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk loci Annals of Human Genetics 77 2 2013 85 105
24. X. Hua, B. Gutman, C.P. Boyle, P. Rajagopalan, A.D. Leow, I. Yanovsky, A.R. Kumar, A.W. Toga, C.R. Jack Jr., N. Schuff, G.E. Alexander, K. Chen, E.M. Reiman, M.W. Weiner, P.M. Thompson, and Alzheimer's Disease Neuroimaging Initiative Accurate measurement of brain changes in longitudinal MRI scans using tensor-based morphometry NeuroImage 57 1 2011 5 14
25. X. Hua, D.P. Hibar, C.R. Ching, C.P. Boyle, P. Rajagopalan, B.A. Gutman, A.D. Leow, A.W. Toga, C.R. Jack Jr., D. Harvey, M.W. Weiner, P.M. Thompson, and the Alzheimer's Disease Neuroimaging Initiative Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials NeuroImage 66C 2013 648 661
26. X. Hua, S. Lee, I. Yanovsky, A.D. Leow, Y.Y. Chou, A.J. Ho, B. Gutman, A.W. Toga, C.R. Jack Jr., M.A. Bernstein, E.M. Reiman, D.J. Harvey, J. Kornak, N. Schuff, G.E. Alexander, M.W. Weiner, and P.M. Thompson Alzheimer's Disease Neuroimaging Initiative, Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects Neuroimage 48 4 2009 668 681
27. M.D. Hurd, P. Martorell, A. Delavande, K.J. Mullen, and K.M. Langa Monetary costs of dementia in the United States The New England Journal of Medicine 368 14 2013 1326 1334
28. J.E. Iglesias, C.Y. Liu, P.M. Thompson, and Z. Tu Robust brain extraction across datasets and comparison with publicly available methods IEEE Transactions on Medical Imaging 30 9 2011 1617 1634
29. A.M. Issa Ethical perspectives on pharmacogenomic profiling in the drug development process Nature Reviews. Drug Discovery 1 4 2002 300 308 (Pubitemid 37361446)
30. C.R. Jack Jr., M.A. Bernstein, N.C. Fox, P. Thompson, G. Alexander, D. Harvey, B. Borowski, P.J. Britson, J.L. Whitwell, C. Ward, A.M. Dale, J.P. Felmlee, J.L. Gunter, D.L. Hill, R. Killiany, N. Schuff, S. Fox-Bosetti, C. Lin, C. Studholme, C.S. DeCarli, G. Krueger, H.A. Ward, G.J. Metzger, K.T. Scott, R. Mallozzi, D. Blezek, J. Levy, J.P. Debbins, A.S. Fleisher, M. Albert, R. Green, G. Bartzokis, G. Glover, J. Mugler, and M.W. Weiner The Alzheimer's Disease Neuroimaging Initiative (ADNI) MRI methods Journal of Magnetic Resonance Imaging 27 4 2008 685 691 (Pubitemid 351508080)
31. J. Jovicich, S. Czanner, D. Greve, E. Haley, A. van der Kouwe, R. Gollub, D. Kennedy, F. Schmitt, G. Brown, J. Macfall, B. Fischl, and A. Dale Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data NeuroImage 30 2 2006 436 443
32. G. Jun, A.C. Naj, G.W. Beecham, L.S. Wang, J. Buros, P.J. Gallins, J.D. Buxbaum, N. Ertekin-Taner, M.D. Fallin, R. Friedland, R. Inzelberg, P. Kramer, E. Rogaeva, P. St George-Hyslop, Alzheimer's Disease Genetics Consortium, L.B. Cantwell, B.A. Dombroski, A.J. Saykin, E.M. Reiman, D.A. Bennett, J.C. Morris, K.L. Lunetta, E.R. Martin, T.J. Montine, A.M. Goate, D. Blacker, D.W. Tsuang, D. Beekly, L.A. Cupples, H. Hakonarson, W. Kukull, T.M. Foroud, J. Haines, R. Mayeux, L.A. Farrer, M.A. Pericak-Vance, and G.D. Schellenberg Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes Archives of Neurology 67 12 2010 1473 1484
33. G. Jun, B.N. Vardarajan, J. Buros, C.E. Yu, M.V. Hawk, B.A. Dombroski, P.K. Crane, E.B. Larson, Alzheimer's Disease Genetics Consortium, R. Mayeux, J.L. Haines, K.L. Lunetta, M.A. Pericak-Vance, G.D. Schellenberg, and L.A. Farrer Comprehensive search for Alzheimer disease susceptibility loci in the APOE region Archives of Neurology 69 10 2012 1270 1279 (Oct.)
34. K. Kingwell Alzheimer disease: BIN1 variant increases risk of Alzheimer disease through tau Nature Reviews. Neurology 9 4 2013 184
35. O. Kohannim, X. Hua, D.P. Hibar, S. Lee, Y.Y. Chou, A.W. Toga, C.R. Jack Jr., M.W. Weiner, P.M. Thompson, and Alzheimer's Disease Neuroimaging Initiative Boosting power for clinical trials using classifiers based on multiple biomarkers Neurobiology of Aging 31 8 2010 1429 1442
36. N. Kozauer, and R. Katz Regulatory innovation and drug development for early-stage Alzheimer's disease The New England Journal of Medicine 368 13 2013 1169 1171
37. J.C. Lambert, S. Heath, G. Even, D. Campion, K. Sleegers, M. Hiltunen, O. Combarros, D. Zelenika, M.J. Bullido, B. Tavernier, L. Letenneur, K. Bettens, C. Berr, F. Pasquier, N. Fiévet, P. Barberger-Gateau, S. Engelborghs, P. De Deyn, I. Mateo, A. Franck, S. Helisalmi, E. Porcellini, O. Hanon, European Alzheimer's Disease Initiative Investigators, M.M. de Pancorbo, C. Lendon, C. Dufouil, C. Jaillard, T. Leveillard, V. Alvarez, P. Bosco, M. Mancuso, F. Panza, B. Nacmias, P. Bossù, P. Piccardi, G. Annoni, D. Seripa, D. Galimberti, D. Hannequin, F. Licastro, H. Soininen, K. Ritchie, H. Blanché, J.F. Dartigues, C. Tzourio, I. Gut, C. Van Broeckhoven, A. Alpérovitch, M. Lathrop, and P. Amouyel Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease Nature Genetics 41 10 2009 1094 1099
38. J.C. Lambert, D. Zelenika, M. Hiltunen, V. Chouraki, O. Combarros, M.J. Bullido, G. Tognoni, N. Fiévet, A. Boland, B. Arosio, E. Coto, M. Del Zompo, I. Mateo, A. Frank-Garcia, S. Helisalmi, E. Porcellini, A. Pilotto, P. Forti, R. Ferri, M. Delepine, E. Scarpini, G. Siciliano, V. Solfrizzi, S. Sorbi, G. Spalletta, G. Ravaglia, F. Valdivieso, V. Alvarez, P. Bosco, M. Mancuso, F. Panza, B. Nacmias, P. Bossù, P. Piccardi, G. Annoni, D. Seripa, D. Galimberti, F. Licastro, M. Lathrop, H. Soininen, and P. Amouyel Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations Neurobiol Aging 32 4 2011 756.e11-5
39. D.R.M. Langers, J.F.A. Jansen, and W.H. Backes Enhanced signal detection in neuroimaging by means of regional control of the global false discovery rate NeuroImage 38 1 2007 43 56 (Pubitemid 47429996)
40. A. Leow, S.C. Huang, A. Geng, J. Becker, S. Davis, A. Toga, and P.M. Thompson Inverse consistent mapping in 3D deformable image registration: its construction and statistical properties Information Processing in Medical Imaging 19 2005 493 503 (Pubitemid 41425340)
41. A.D. Leow, A.D. Klunder, C.R. Jack Jr., A.W. Toga, A.M. Dale, M.A. Bernstein, P.J. Britson, J.L. Gunter, C.P. Ward, J.L. Whitwell, B.J. Borowski, A.S. Fleisher, N.C. Fox, D. Harvey, J. Kornak, N. Schuff, C. Studholme, G.E. Alexander, M.W. Weiner, P.M. Thompson, and ADNI Preparatory Phase Study Longitudinal stability of MRI for mapping brain change using tensor-based morphometry NeuroImage 31 2 2006 627 640 (Pubitemid 44218807)
42. K.K. Leung, J. Barnes, G.R. Ridgway, J.W. Bartlett, M.J. Clarkson, K. Macdonald, N. Schuff, N.C. Fox, S. Ourselin, and for the Alzheimer's Disease Neuroimaging Initiative Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease NeuroImage 51 4 2010 1345 1359
43. M. Lorenzi, M. Donohue, D. Paternicò, C. Scarpazza, S. Ostrowitzki, O. Blin, E. Irving, G.B. Frisoni, and for the Alzheimer's Disease Neuroimaging Initiative Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment Neurobiology of Aging 31 8 2010 1443 1451
44. L.K. McEvoy, S.D. Edland, D. Holland, D.J. Hagler Jr., J.C. Roddey, C. Fennema-Notestine, D.P. Salmon, A.K. Koyama, P.S. Aisen, J.B. Brewer, A.M. Dale, and for the Alzheimer's Disease Neuroimaging Initiative Neuroimaging enrichment strategy for secondary prevention trials in Alzheimer disease Alzheimer Disease and Associated Disorders 24 3 2010 269 277
45. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 7 1984 939 944 (Pubitemid 14076461)
46. J.C. Morris The Clinical Dementia Rating (CDR). Current version and scoring rules Neurology 43 11 1993 2412 2414 (Pubitemid 23346995)
47. J.C. Morris, C.M. Roe, C. Xiong, A.M. Fagan, A.M. Goate, D.M. Holtzman, and M.A. Mintun APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging Annals of Neurology 67 1 2010 122 131
48. A.C. Morrison, L.A. Bare, L.E. Chambless, S.G. Ellis, M. Malloy, J.P. Kane, J.S. Pankow, J.J. Devlin, J.T. Willerson, and E. Boerwinkle Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities study American Journal of Epidemiology 166 1 2007 28 35 (Pubitemid 47234300)
49. S.M. Nestor, R. Rupsingh, M. Borrie, M. Smith, V. Accomazzi, J.L. Wells, J. Fogarty, R. Bartha, and Alzheimer's Disease Neuroimaging Initiative Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database Brain 131 9 2008 2443 2454
50. S.G. Potkin, G. Guffanti, A. Lakatos, J.A. Turner, F. Kruggel, J.H. Fallon, A.J. Saykin, A. Orro, S. Lupoli, E. Salvi, M. Weiner, F. Macciardi, and Alzheimer's Disease Neuroimaging Initiative Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease PLoS One 4 8 2009 e6501
51. Q. Qi, Y. Li, A.K. Chomistek, J.H. Kang, G.C. Curhan, L.R. Pasquale, W.C. Willett, E.B. Rimm, F.B. Hu, and L. Qi Physical activity, television watching and genetic predisposition in relation to body mass index in women and men Epidemiology and Prevention/Nutrition, Physical Activity and Metabolism Scientific Sessions 2012
52. S.L. Risacher, L. Shen, J.D. West, S. Kim, B.C. McDonald, L.A. Beckett, D.J. Harvey, C.R. Jack Jr., M.W. Weiner, A.J. Saykin, and Alzheimer's Disease Neuroimaging Initiative Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort Neurobiology of Aging 31 8 2010 1401 1418
53. A.D. Roses The medical and economic roles of pipeline pharmacogenetics: Alzheimer's disease as a model of efficacy and HLA-B(*)5701 as a model of safety Neuropsychopharmacology 34 1 2009 6 17
54. A.D. Roses, M.W. Lutz, H. Amrine-Madsen, A.M. Saunders, D.G. Crenshaw, S.S. Sundseth, M.J. Huentelman, K.A. Welsh-Bohmer, and E.M. Reiman A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease The Pharmacogenomics Journal 10 5 2010 375 384
55. A.J. Saykin, L. Shen, T.M. Foroud, S.G. Potkin, S. Swaminathan, S. Kim, S.L. Risacher, K. Nho, M.J. Huentelman, D.W. Craig, P.M. Thompson, J.L. Stein, J.H. Moore, L.A. Farrer, R.C. Green, L. Bertram, C.R. Jack Jr., M.W. Weiner, and Alzheimer's Disease Neuroimaging Initiative Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: genetics core aims progress and plans Alzheimer's & Dementia 6 3 2010 265 273
56. N.J. Schork, and E.J. Topol Genotype-based risk and pharmacogenetic sampling in clinical trials Journal of Biopharmaceutical Statistics 20 2 2010 315 333
57. J.G. Sled, A.P. Zijdenbos, and A.C. Evans A nonparametric method for automatic correction of intensity nonuniformity in MRI data IEEE Transactions on Medical Imaging 17 1 1998 87 97 (Pubitemid 128742012)
58. K. Sleegers, J.C. Lambert, L. Bertram, M. Cruts, P. Amouyel, and C. Van Broeckhoven The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects Trends in Genetics 26 2 2010 84 93
59. J.L. Stein, X. Hua, J.H. Morra, S. Lee, D.P. Hibar, A.J. Ho, A.D. Leow, A.W. Toga, J.H. Sul, H.M. Kang, E. Eskin, A.J. Saykin, L. Shen, T. Foroud, N. Pankratz, M.J. Huentelman, D.W. Craig, J.D. Gerber, A.N. Allen, J.J. Corneveaux, D.A. Stephan, J. Webster, B.M. DeChairo, S.G. Potkin, C.R. Jack Jr., M.W. Weiner, P.M. Thompson, and Alzheimer's Disease Neuroimaging Initiative Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease NeuroImage 51 2 2010 542 554
60. P.J. Visser, P. Scheltens, and F.R. Verhey Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease? J Neurol Neurosurg Psychiatry 76 10 2005 1348 1354 (Pubitemid 41360969)
61. M.W. Weiner, D.P. Veitch, P.S. Aisen, L.A. Beckett, N.J. Cairns, R.C. Green, D. Harvey, C.R. Jack, W. Jagust, E. Liu, J.C. Morris, R.C. Petersen, A.J. Saykin, M.E. Schmidt, L. Shaw, J.A. Siuciak, H. Soares, A.W. Toga, and J.Q. Trojanowski Alzheimer's Disease Neuroimaging Initiative, The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception Alzheimers Dement 8 1 Suppl 2012 S1 68
62. M. Zamani, M. Mehri, A. Kollaee, P. Yenki, M. Ghaffarpor, M.H. Harirchian, and M. Shahbazi Pharmacogenetic study on the effect of rivastigmine on PS2 and APOE genes in Iranian Alzheimer patients Dementia and Geriatric Cognitive Disorders Extra 1 1 2011 180 189 Bioengineering Bioengineering Bioengineering Development